Cargando…
Is the Combination of ICS and LABA, a Therapeutic Option for COPD, Fading Away?
| Autor principal: | |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
The Korean Academy of Tuberculosis and Respiratory Diseases
2017
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5256351/ https://www.ncbi.nlm.nih.gov/pubmed/28119753 http://dx.doi.org/10.4046/trd.2017.80.1.93 |
| _version_ | 1782498697949478912 |
|---|---|
| author | Oh, Yeon-Mok |
| author_facet | Oh, Yeon-Mok |
| author_sort | Oh, Yeon-Mok |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-5256351 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2017 |
| publisher | The Korean Academy of Tuberculosis and Respiratory Diseases |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-52563512017-01-24 Is the Combination of ICS and LABA, a Therapeutic Option for COPD, Fading Away? Oh, Yeon-Mok Tuberc Respir Dis (Seoul) Editorial The Korean Academy of Tuberculosis and Respiratory Diseases 2017-01 2016-12-30 /pmc/articles/PMC5256351/ /pubmed/28119753 http://dx.doi.org/10.4046/trd.2017.80.1.93 Text en Copyright©2017. The Korean Academy of Tuberculosis and Respiratory Diseases. All rights reserved. http://creativecommons.org/licenses/by-nc/4.0/ It is identical to the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/) |
| spellingShingle | Editorial Oh, Yeon-Mok Is the Combination of ICS and LABA, a Therapeutic Option for COPD, Fading Away? |
| title | Is the Combination of ICS and LABA, a Therapeutic Option for COPD, Fading Away? |
| title_full | Is the Combination of ICS and LABA, a Therapeutic Option for COPD, Fading Away? |
| title_fullStr | Is the Combination of ICS and LABA, a Therapeutic Option for COPD, Fading Away? |
| title_full_unstemmed | Is the Combination of ICS and LABA, a Therapeutic Option for COPD, Fading Away? |
| title_short | Is the Combination of ICS and LABA, a Therapeutic Option for COPD, Fading Away? |
| title_sort | is the combination of ics and laba, a therapeutic option for copd, fading away? |
| topic | Editorial |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5256351/ https://www.ncbi.nlm.nih.gov/pubmed/28119753 http://dx.doi.org/10.4046/trd.2017.80.1.93 |
| work_keys_str_mv | AT ohyeonmok isthecombinationoficsandlabaatherapeuticoptionforcopdfadingaway |